Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Lardizabal

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Open Forum Infectious Diseases|January 16, 2026
Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022-2024Rina Liang, James C M Brust, Caitlin Reed, et al.
Journal of Immunological Methods|October 11, 2021
Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection and vaccinationPratik Datta, Rahul Ukey, Natalie Bruiners, et al.
American Journal of Respiratory and Critical Care Medicine|November 16, 2019
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelinePayam Nahid, Sundari R Mase, Giovanni Battista Migliori, et al.
Medrxiv : the Preprint Server for Health Sciences|July 20, 2021
Highly versatile antibody binding assay for the detection of SARS-CoV-2 infectionPratik Datta, Rahul Ukey, Natalie Bruiners, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 21, 2025
Accuracy of VIDAS® TB-IGRA in TB patients and individuals with different thresholds of exposureDelia Goletti, Niaz Banaei, Rahul Batra, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Open Forum Infectious Diseases|January 16, 2026
Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022-2024Rina Liang, James C M Brust, Caitlin Reed, et al.
Journal of Immunological Methods|October 11, 2021
Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection and vaccinationPratik Datta, Rahul Ukey, Natalie Bruiners, et al.
American Journal of Respiratory and Critical Care Medicine|November 16, 2019
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelinePayam Nahid, Sundari R Mase, Giovanni Battista Migliori, et al.
Medrxiv : the Preprint Server for Health Sciences|July 20, 2021
Highly versatile antibody binding assay for the detection of SARS-CoV-2 infectionPratik Datta, Rahul Ukey, Natalie Bruiners, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 21, 2025
Accuracy of VIDAS® TB-IGRA in TB patients and individuals with different thresholds of exposureDelia Goletti, Niaz Banaei, Rahul Batra, et al.
Pageof 3